Noel Bell, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-484-2777 Fax: 517-484-7377 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that data from the second Phase III trial of microplasmin (TG-MV-007) for the non-surgical treatment of vitreomacular adhesion (VMA), are to be presented at the 28th Annual Meeting of the American Society of Retina Specialists (ASRS) and the 10th EURETINA Congress.
"Africa has the highest maternal mortality rates in the world, with 48 percent of all global maternal deaths occurring in this region," Jotham Musinguzi, regional director of the Partners in Population and Development Africa Regional Office in Kampala, Uganda, writes in an Independent opinion piece.
Abraxis BioScience, Inc., a fully integrated biotechnology company, previously announced it will be presenting more than 30 studies, including new clinical data evaluating the use of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable suspension; paclitaxel protein albumin-bound particles for injectable suspension) for the treatment of pancreatic cancer at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago.
The best time to push during the second stage of labor (when the cervix is completely dilated through delivery) is unknown and it's unclear whether the timing affects rates of natural delivery or possible complications.
A team of researchers used several assays, atomic force microscopy, and simulations to determine that the N501Y mutation in the virus's receptor-binding domain (RBD) increased the interaction of the virus with the angiotensin-converting enzyme 2 (ACE2) receptor.
› Verified 4 days ago